LEMAITRE VASCULAR, INC. Proceeds from Divestiture of Businesses
LEMAITRE VASCULAR, INC. (LMAT) reported Proceeds from Divestiture of Businesses of $0 for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-12.
Discontinued › Cash Flow › Investing Activities
us-gaap:ProceedsFromDivestitureOfBusinesses · last filed 2021-03-12
- LEMAITRE VASCULAR, INC. proceeds from divestiture of businesses for the quarter ending 2018-12-31 was $0.00.
- LEMAITRE VASCULAR, INC. proceeds from divestiture of businesses for the quarter ending 2018-09-30 was $0.00.
- LEMAITRE VASCULAR, INC. proceeds from divestiture of businesses for the quarter ending 2015-12-31 was $0.00.
- LEMAITRE VASCULAR, INC. proceeds from divestiture of businesses for the quarter ending 2012-12-31 was $250.00K, a 8233.33% increase year-over-year.
- LEMAITRE VASCULAR, INC. proceeds from divestiture of businesses for fiscal 2020 was $0.00.
- LEMAITRE VASCULAR, INC. proceeds from divestiture of businesses for fiscal 2019 was $0.00, a 100.00% decline from fiscal 2018.
- LEMAITRE VASCULAR, INC. proceeds from divestiture of businesses for fiscal 2018 was $7.40M.
- LEMAITRE VASCULAR, INC. proceeds from divestiture of businesses for fiscal 2015 was $360.00K.
| Period end | Proceeds from Divestiture of Businesses 3 month | Proceeds from Divestiture of Businesses 6 month | Proceeds from Divestiture of Businesses 9 month | Proceeds from Divestiture of Businesses 12 month |
|---|---|---|---|---|
| 2020-12-31 | $0.00 10-K · filed 2021-03-12 | |||
| 2019-12-31 | $0.00 10-K · filed 2021-03-12 | |||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | $0.00 derived: sum of 2 quarters · filed 2021-03-12 | $7.40M 10-K · filed 2021-03-12 | |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | $7.40M 10-Q · filed 2019-11-08 | ||
| 2018-06-30 | $7.40M 10-Q · filed 2019-08-06 | |||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09 | $360.00K 10-K · filed 2018-03-09 | ||
| 2015-09-30 | $360.00K 10-Q · filed 2016-11-04 | |||
| 2012-12-31 | $250.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-18 | $365.00K derived: sum of 2 quarters · filed 2015-03-18 | $496.00K derived: sum of 3 quarters · filed 2015-03-18 | $500.00K 10-K · filed 2015-03-18 |
| 2012-09-30 | $115.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | $246.00K derived: sum of 2 quarters · filed 2013-11-07 | $250.00K 10-Q · filed 2013-11-07 | $253.00K derived: sum of 4 quarters · filed 2014-03-21 |
| 2012-06-30 | $131.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | $135.00K 10-Q · filed 2013-08-09 | $138.00K derived: sum of 3 quarters · filed 2014-03-21 | $1.44M derived: sum of 4 quarters · filed 2014-03-21 |
| 2012-03-31 | $4.00K 10-Q · filed 2013-05-08 | $7.00K derived: sum of 2 quarters · filed 2014-03-21 | $1.31M derived: sum of 3 quarters · filed 2014-03-21 | $1.41M derived: sum of 4 quarters · filed 2014-03-21 |
| 2011-12-31 | $3.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-21 | $1.31M derived: sum of 2 quarters · filed 2014-03-21 | $1.41M derived: sum of 3 quarters · filed 2014-03-21 | $1.41M 10-K · filed 2014-03-21 |
| 2011-09-30 | $1.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | $1.41M derived: sum of 2 quarters · filed 2012-11-09 | $1.41M 10-Q · filed 2012-11-09 | $1.42M derived: sum of 4 quarters · filed 2013-03-27 |
| 2011-06-30 | $102.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-10 | $108.00K 10-Q · filed 2012-08-10 | $115.00K derived: sum of 3 quarters · filed 2013-03-27 | $117.00K derived: sum of 4 quarters · filed 2013-03-27 |
| 2011-03-31 | $6.00K 10-Q · filed 2012-05-03 | $13.00K derived: sum of 2 quarters · filed 2013-03-27 | $15.00K derived: sum of 3 quarters · filed 2013-03-27 | |
| 2010-12-31 | $7.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-27 | $9.00K derived: sum of 2 quarters · filed 2013-03-27 | $40.00K 10-K · filed 2013-03-27 | |
| 2010-09-30 | $2.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14 | $33.00K 10-Q · filed 2011-11-14 | ||
| 2010-06-30 | $31.00K 10-Q · filed 2011-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |